These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3397188)

  • 1. Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice.
    Davidson MK; Davis JK; Lindsey JR; Cassell GH
    Infect Immun; 1988 Aug; 56(8):2163-8. PubMed ID: 3397188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in virulence for mice among strains of Mycoplasma pulmonis.
    Davidson MK; Lindsey JR; Parker RF; Tully JG; Cassell GH
    Infect Immun; 1988 Aug; 56(8):2156-62. PubMed ID: 3397187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of viral and mycoplasmal infections, ammonia exposure, vitamin A deficiency, host age, and organism strain on adherence of Mycoplasma pulmonis in cultured rat tracheas.
    Schoeb TR; Juliana MM; Nichols PW; Davis JK; Lindsey JR
    Lab Anim Sci; 1993 Oct; 43(5):417-24. PubMed ID: 8277719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.
    Cartner SC; Simecka JW; Lindsey JR; Cassell GH; Davis JK
    Infect Immun; 1995 Oct; 63(10):4138-42. PubMed ID: 7558330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.
    Parker RF; Davis JK; Blalock DK; Thorp RB; Simecka JW; Cassell GH
    Infect Immun; 1987 Nov; 55(11):2631-5. PubMed ID: 3666955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
    Davis JK; Davidson M; Schoeb TR
    Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis.
    Parker RF; Davis JK; Cassell GH; White H; Dziedzic D; Blalock DK; Thorp RB; Simecka JW
    Am Rev Respir Dis; 1989 Aug; 140(2):502-12. PubMed ID: 2504091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice.
    Hickman-Davis JM; Michalek SM; Gibbs-Erwin J; Lindsey JR
    Infect Immun; 1997 Jun; 65(6):2278-82. PubMed ID: 9169764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.
    Faulkner CB; Simecka JW; Davidson MK; Davis JK; Schoeb TR; Lindsey JR; Everson MP
    Infect Immun; 1995 Oct; 63(10):4084-90. PubMed ID: 7558323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice.
    Davis JK; Parker RF; White H; Dziedzic D; Taylor G; Davidson MK; Cox NR; Cassell GH
    Infect Immun; 1985 Dec; 50(3):647-54. PubMed ID: 4066026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice.
    Taylor G; Howard CJ; Gourlay RN
    Infect Immun; 1977 May; 16(2):422-31. PubMed ID: 558962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.
    Simmons WL; Dybvig K
    Infect Immun; 2003 Oct; 71(10):5733-8. PubMed ID: 14500494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stages in the interaction between Mycoplasma gallisepticum and the chick trachea, as related to pathogenicity and immunogenicity.
    Levisohn S
    Isr J Med Sci; 1984 Oct; 20(10):982-4. PubMed ID: 6511325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycoplasma pulmonis infection in gnotobiotic and conventional mice: aspects of pathogenicity including microbial enumeration and studies of tracheal involvement.
    Organick AB; Lutsky II
    Lab Anim Sci; 1976 Jun; 26(3):419-29. PubMed ID: 940302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.
    Mize MT; Sun XL; Simecka JW
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplasmal adherence with particular reference to the pathogenicity of Mycoplasma pulmonis.
    Taylor-Robinson D; Furr PM; Davies HA; Manchee RJ; Mouches C; Bove JM
    Isr J Med Sci; 1981 Jul; 17(7):599-603. PubMed ID: 7026496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracage ammonia promotes growth of Mycoplasma pulmonis in the respiratory tract of rats.
    Schoeb TR; Davidson MK; Lindsey JR
    Infect Immun; 1982 Oct; 38(1):212-7. PubMed ID: 7141691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats.
    Gumulak-Smith J; Teachman A; Tu AH; Simecka JW; Lindsey JR; Dybvig K
    Mol Microbiol; 2001 May; 40(4):1037-44. PubMed ID: 11401710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an aerosol model of murine respiratory mycoplasmosis in mice.
    Davis JK; Thorp RB; Parker RF; White H; Dziedzic D; D'Arcy J; Cassell GH
    Infect Immun; 1986 Oct; 54(1):194-201. PubMed ID: 3759235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions.
    Talkington DF; Fallon MT; Watson HL; Thorp RK; Cassell GH
    Microb Pathog; 1989 Dec; 7(6):429-36. PubMed ID: 2622331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.